| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2026 | 17 | 170,365 | ALLO, CELC, ARVN, PYXS | 13F-HR | 8/13/2026 | 000007800326000102 |
| Q1 2026 | 18 | 238,775 | ORIC, ALLO, ARVN, CELC | 13F-HR | 5/12/2026 | 000007800326000064 |
| Q4 2025 | 18 | 236,464 | ORIC, ARVN, CELC, WVE | 13F-HR | 2/12/2026 | 000007800326000013 |
| Q3 2025 | 21 | 437,450 | BNTX, ORIC, TRML, ARVN | 13F-HR | 11/13/2025 | 000007800325000161 |
| Q2 2025 | 21 | 576,193 | BNTX, ORIC, ARVN, ALLO | 13F-HR | 8/11/2025 | 000007800325000142 |
| Q1 2025 | 21 | 500,836 | BNTX, ALLO, ORIC, ARVN | 13F-HR | 5/13/2025 | 000007800325000118 |
| Q4 2024 | 23 | 2,592,004 | HLN, BNTX, ARVN, ALLO | 13F-HR | 2/14/2025 | 000007800325000048 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.
| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
|
Allogene Therapeutics, Inc.
13D/A
ALLO · 019770106
|
9.0% |
2/13/2026
Event 11/6/2025
|
||||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||||
|
Haleon plc
13D/A
HLN · 405552100
|
0% |
3/24/2025
Event 3/21/2025
|
||||
6 other securities where the latest filing is a 13G, the newest filed 10/16/2026. View all